文献速递皮肤肿瘤

远程皮肤共聚焦显微镜在黑色素瘤和角质形成细胞癌中的诊断准确性:多中心前瞻性研究

Remote cutaneous confocal microscopy: A multicentric prospective study evaluating diagnostic accuracy for melanoma and keratinocyte carcinoma in tertiary settings.
PubMed 文献 · J Am Acad Dermatol · 2024-10-09

这项多中心前瞻性研究在5个澳大利亚三级皮肤病中心招募了201例拟活检的皮肤恶性病变,评估远程皮肤共聚焦显微镜(remote-CCM)的诊断准确性和安全性。结果显示,remote-CCM检测恶性肿瘤的敏感性为89%(95%CI 79%-95%),特异性为64%(95%CI 55%-73%)。在89例可能免于活检的病变中,80例(90%)为良性,9例(10.1%)为漏诊恶性病变(7例原位黑色素瘤和2例鳞状细胞癌),无侵袭性黑色素瘤漏诊。

要点

  • 远程CCM对恶性肿瘤的敏感性为89%,特异性为64%,与床旁CCM准确性相当。
  • 远程CCM可安全减少不必要的活检,但可能漏诊原位黑色素瘤和SCC。
  • 疑似SCC的病变不适合采用远程CCM,交界性黑素细胞病变建议随访。

核心结论

  • 远程CCM与床旁CCM准确性相当,可安全减少不必要的活检。
  • 疑似SCC的病变不适合远程CCM,交界性黑素细胞病变建议随访。

研究设计与样本

  • 前瞻性多中心研究,在5个澳大利亚三级皮肤病中心招募201例拟活检的皮肤恶性病变。
  • 活检前获取CCM、临床和皮肤镜图像,通过云平台由CCM阅读者解读,并与组织病理学结果比较。

主要发现

  • 共纳入201例病变,黑色素瘤是最常见的恶性肿瘤(34/72,47.2%)。
  • 89例(44.8%)可能免于活检的病变中,80例(90%)为良性,9例(10.1%)为漏诊恶性病变(原位黑色素瘤7例,SCC 2例)。
  • 无侵袭性黑色素瘤漏诊。
  • 远程CCM检测恶性肿瘤的敏感性为89%(95%CI 79%-95%),特异性为64%(95%CI 55%-73%)。

临床怎么用

  • 远程CCM可用于减少不必要的活检,但需注意可能漏诊原位黑色素瘤和SCC。
  • 疑似SCC的病变不应使用远程CCM评估。
  • 交界性黑素细胞病变建议进行随访。

局限性

  • 研究招募自高危人群,且排除了未活检的病变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cutaneous confocal microscopy (CCM) facilitates in vivo visualization of skin at a cellular level. Use of a "store and forward" approach for remote-CCM interpretation (remote-CCM) across multiple sites has not been tested and may increase access to noninvasive diagnosis. OBJECTIVES: To test the diagnostic accuracy and safety of remote-CCM. METHODS: We prospectively recruited lesions selected for biopsy for skin malignancy across 5 Australian tertiary dermatology centers. CCM, clinical and dermatoscopy images were acquired prebiopsy and accessed by a cloud-based platform for interpretation by CCM readers. CCM diagnosis was compared with histopathology results. RESULTS: Among the 201 lesions included, melanoma was the most common malignancy (34/72, 47.2%). Of the 89 lesions (44.8%) potentially "saved" from biopsy, 80 (90%) were truly benign lesions and 9 (10.1%) were missed malignant lesions of melanoma in situ (n = 7) and squamous cell carcinoma (SCC) (n = 2). No invasive melanomas were missed. Sensitivity of remote-CCM for detection of malignancy was 89% (95% CI, 79%-95%) and specificity was 64% (95% CI, 55%-73%). LIMITATIONS: The study recruited from high-risk populations and excluded lesions that were not biopsied. CONCLUSIONS: Remote-CCM has comparable accuracy to bedside CCM and safely reduces unnecessary biopsies. Potential SCCs are not appropriate for remote-CCM. Follow-up of borderline melanocytic lesions is recommended.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Ho G, Collgros H, Sinz C, et al. Remote cutaneous confocal microscopy: A multicentric prospective study evaluating diagnostic accuracy for melanoma and keratinocyte carcinoma in tertiary settings. J Am Acad Dermatol. 2024. PMID: 39389425. doi:10.1016/j.jaad.2024.09.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。